Autoimmune & Inflammatory Diseases
The immune system has the capacity to mount an immune response to certainly all molecules and/or cells. Although the potential to respond to self-antigen is present in absolutely everyone, in most times such responses bring about tolerance, indicating that mechanisms should exist to save you or subdue autoimmune responses. Furthermore, automobile-reactive T and B cells, in addition to auto-antibodies, are observed in folks that do no longer have autoimmune diseases, demonstrating that immunological automobile-reactivity alone isn't sufficient for the improvement of the sickness. The mechanisms currently thought to save you/dampen autoimmune responses include inactivation or deletion of auto-reactive B and T cells, lively suppression by using cells or cytokines, idiotype or anti-idiotype interactions, and the immunosuppressive adrenal hormones, the glucocorticoids. While dampening mechanisms fail or are overridden, a reaction directed against self-antigen can occur, resulting in autoimmune illnesses that range from the ones which are organ-unique (diabetes and thyroiditis) to the ones which can be systemic (non-organ specific) together with systemic lupus erythematosus and rheumatoid arthritis.
<p justify;"="">
- Autoimmune Research
- Inflammation
- Immunometabolism & Its Regulator
- Immunomodulatory Effects on Immune System
- Immunotherapy
- Radio Immunotherapy & Cancer Vaccines Development
- Current Evidence and Future Perspectives of Autoimmunity
- Future Immunomodulation Strategies
- Immunomodulatory Xenobiotics
Related Conference of Autoimmune & Inflammatory Diseases
9th International Conference on Vaccines, Immunology and Clinical Trials
7th International conference on Vaccines, Vaccination and Immunization
Autoimmune & Inflammatory Diseases Conference Speakers
Recommended Sessions
- Animal and Plant derived Vaccines
- Autoimmune & Inflammatory Diseases
- Bacterial Vaccines
- Cancer Malaria & Tuberculosis Vaccines
- Childhood and Maternal Vaccines
- Combination and Conjugate Vaccines
- DNA and Synthetic Vaccines
- Giving Vaccination
- HIV Vaccines
- Immune Diseases
- Immunology and Disease
- Immunoresearch and Immunotechnology
- Pediatric Vaccines
- Toxoid Vaccines
- Tuberculosis Vaccines
- Types of Vaccines
- Vaccines
- Vaccines Production and Development
- Veterinary Vaccines
- Zika Virus Vaccines
Related Journals
Are you interested in
- Advancements in Vaccine Research and Development - Vaccines R&D 2026 (France)
- Advances in Pediatric Vaccines - Vaccines R&D 2026 (France)
- Animal & Plant Derived Vaccines - Vaccines-Immunization-2026 (France)
- Animal Models & Clinical Trials - Vaccines-Immunization-2026 (France)
- Antibodies: Engineering & Therapeutics - Vaccines-Immunization-2026 (France)
- Bioinformatics and AI in Vaccine Design - Vaccine Immunology 2026 (France)
- Cancer, Malaria & TB Vaccines - Vaccines-Immunization-2026 (France)
- Cellular Immunology & Latest Innovations - Vaccines-Immunization-2026 (France)
- Challenges in Vaccine Accessibility and Equity - Vaccine Immunology 2026 (France)
- Clinical Trials Design and Methodologies - Vaccines R&D 2026 (France)
- Clinical Vaccinology and Immunotherapy - Vaccine Immunology 2026 (France)
- Combination & Conjugate Vaccines - Vaccines-Immunization-2026 (France)
- Current Research & Future Challenges - Vaccines-Immunization-2026 (France)
- DNA & Synthetic Vaccines - Vaccines-Immunization-2026 (France)
- Emerging Infectious Diseases - Vaccine Immunology 2026 (France)
- Emerging Infectious Diseases and Vaccine Development - Vaccines R&D 2026 (France)
- Ethical Considerations in Vaccine Development and Distribution - Vaccines R&D 2026 (France)
- Fish & Poultry Vaccines - Vaccines-Immunization-2026 (France)
- Future Directions in Vaccine Research - Vaccine Immunology 2026 (France)
- Geriatric Immunization - Vaccines-Immunization-2026 (France)
- Global Immunization Strategies and Policy - Vaccines R&D 2026 (France)
- Global Vaccination Strategies - Vaccine Immunology 2026 (France)
- HIV Vaccines - Vaccines-Immunization-2026 (France)
- Human Microbiome and Vaccines - Vaccine Immunology 2026 (France)
- Immunogenetics and Personalized Vaccines - Vaccine Immunology 2026 (France)
- Immunogenetics and Personalized Vaccines - Vaccine Immunology 2026 (France)
- Immunology and Immune System Innovations - Vaccine Immunology 2026 (France)
- Immunology of Infectious Diseases - Vaccine Immunology 2026 (France)
- Immunology of Infectious Diseases - Vaccines R&D 2026 (France)
- Immunotherapy and Personalized Medicine - Vaccines R&D 2026 (France)
- Immunotherapy and Vaccines for Non-Infectious Diseases - Vaccine Immunology 2026 (France)
- Immunotherapy in Cancer Treatment - Vaccine Immunology 2026 (France)
- Industry and Technology Innovations - Vaccine Immunology 2026 (France)
- Innovations in Vaccine Cold Chain and Storage - Vaccines R&D 2026 (France)
- Maternal, Neonatal, and Geriatric Immunization - Vaccine Immunology 2026 (France)
- Microbiome-Targeted Vaccines - Vaccine Immunology 2026 (France)
- Nanotechnology and Advanced Delivery Systems - Vaccine Immunology 2026 (France)
- Nanotechnology in Vaccine Delivery - Vaccine Immunology 2026 (France)
- Next-Generation Vaccine Platforms - Vaccine Immunology 2026 (France)
- Novel Vaccine Platforms: mRNA, DNA, and Viral Vectors - Vaccine Immunology 2026 (France)
- One Health Approach to Vaccine Development - Vaccine Immunology 2026 (France)
- Paediatric Vaccination - Vaccines-Immunization-2026 (France)
- Pandemic Preparedness and Response - Vaccine Immunology 2026 (France)
- Public Health and Global Immunization - Vaccine Immunology 2026 (France)
- Regulatory Approaches in Vaccine Development - Vaccines R&D 2026 (France)
- Role of Adjuvants in Vaccine Efficacy - Vaccines R&D 2026 (France)
- Role of AI and Big Data in Vaccine Research - Vaccines R&D 2026 (France)
- The Economics of Vaccination - Vaccine Immunology 2026 (France)
- Translational Immunology and Vaccine Development - Vaccines R&D 2026 (France)
- Travel & Edible Vaccines - Vaccines-Immunization-2026 (France)
- Vaccine Delivery Systems: Innovations and Challenges - Vaccines R&D 2026 (France)
- Vaccine Development for Cancer Immunotherapy - Vaccines R&D 2026 (France)
- Vaccine Development for Vector-Borne Diseases - Vaccines R&D 2026 (France)
- Vaccine Equity and Access in Low-Resource Settings - Vaccines R&D 2026 (France)
- Vaccine Hesitancy and Public Perception - Vaccines R&D 2026 (France)
- Vaccine Hesitancy and Public Trust - Vaccine Immunology 2026 (France)
- Vaccine Manufacturing and Distribution - Vaccines R&D 2026 (France)
- Vaccine Production & Development - Vaccines-Immunization-2026 (France)
- Vaccine Production and Global Supply Chains - Vaccine Immunology 2026 (France)
- Vaccine Research and Development - Vaccine Immunology 2026 (France)
- Vaccine Safety and Adverse Event Monitoring - Vaccine Immunology 2026 (France)
- Vaccine Safety and Pharmacovigilance - Vaccines R&D 2026 (France)
- Vaccine Safety, Pharmacovigilance, and Adverse Event Monitoring - Vaccine Immunology 2026 (France)
- Vaccine-Induced Immunity and Duration of Protection - Vaccine Immunology 2026 (France)
- Vaccines - Vaccines-Immunization-2026 (France)
- Vaccines & Autism - Vaccines-Immunization-2026 (France)
- Vaccines against Drugs - Vaccines-Immunization-2026 (France)
- Vaccines against Infectious Diseases - Vaccines-Immunization-2026 (France)
- Vaccines for Immune Mediated Diseases - Vaccines-Immunization-2026 (France)
- Vaccines for Pregnant Women & Neonates - Vaccines-Immunization-2026 (France)
- Vaccines for Unconventional Diseases - Vaccines-Immunization-2026 (France)
- Vectors, Adjuvants & Delivery Systems - Vaccines-Immunization-2026 (France)

